Every 15 minutes, a baby is born with a congenital heart defect. Behind that statistic is a family whose world has just changed forever.
Your Donation Multiplies Impact
The Children's Heart Foundation funds breakthrough research that saves lives. When you support The Children's Heart Foundation, your gift becomes seed funding that helps researchers secure major federal grants. Our track record proves it works: our top five researchers have transformed initial CHF grants of $755,000 into over $25 million in additional funding, producing 303 publications that directly improve care for children with heart defects.
Why Support The Children's Heart Foundation?
We fund the most promising research for congenital heart defects.
Your contribution unlocks additional funding from NIH and other major sources.
Our researchers' discoveries translate into better treatments for thousands of children.
Every gift—whether $100 or $5,000—ignites a cascade of lifesaving discoveries
Jane W. Newburger, MD, MPH is Commonwealth Professor of Pediatrics at Harvard Medical School and Associate Cardiologist-in-Chief for Academic Affairs at Boston Children's Hospital. An international authority in pediatric cardiovascular disease, her research focuses on clinical outcomes and neurodevelopment in congenital heart disease, Kawasaki disease, and multisystem inflammatory syndrome in children.
Dr. Newburger has published over 600 peer-reviewed manuscripts and is a member of the National Academy of Medicine. She has received the Distinguished Scientist Award from the American College of Cardiology, the Clinical Research Prize from the American Heart Association, and mentoring awards from Harvard Medical School.
Her work with CHF demonstrates our impact: Dr. Newburger's research, initially supported by The Children's Heart Foundation in 2010, has generated 67 peer-reviewed publications that have changed how doctors approach pediatric cardiac care. Continuously funded by NIH since 1982, she maintains an active clinical practice treating children with heart disease.
Christopher K. Breuer, MD, is Co-Director of the Tissue Engineering Program at Nationwide Children's Hospital and Director of Tissue Engineering at The Ohio State University Wexner Medical Center's Center for Regenerative Medicine and Cell-Based Therapies. His clinical and research interests focus on bioengineered tissue for surgical applications.
Working with Dr. Toshiharu Shinoka, Dr. Breuer was the first in the world to tissue engineer blood vessels and implant them in human infants. He has received numerous honors, including the Jacobsen Promising Investigator Award from the American College of Surgeons, given to the most innovative young surgical investigator in the country.
His work with CHF demonstrates our impact: Dr. Breuer, whom The Children's Heart Foundation first funded in 2014, has since secured millions in federal grants that led to breakthrough treatments now helping children worldwide.
